Stay updated on KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.

Latest updates to the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a new revision entry v3.5.0 and deleted the previous revision v3.4.3 in the study record history.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check29 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed from the study record history.SummaryDifference0.1%

- Check58 days agoChange DetectedA new system revision (v3.4.2) was added to the history, and an existing government funding/operating status notice was removed; the previous revision (v3.4.1) remains listed. The changes are administrative in nature and do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check65 days agoChange DetectedA site-wide funding notice was added and the Record History shows a new revision label (v3.4.1). These updates are administrative and do not alter the trial data or study details.SummaryDifference0.9%

- Check72 days agoChange DetectedThe history page now shows a glossary option, green highlights for additions and red highlights for deletions, and an updated revision label (v3.4.0) with minor wording changes like 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check79 days agoChange DetectedThe Record History shows a new revision entry v3.3.4 and removes v3.3.3, reflecting a minor update to the historical record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN026 with Docetaxel in HER2+ Breast Cancer Clinical Trial page.